Skip to main content

GSK, RA Capital Report Major WVE Activity

The most significant insider activity today involves Wave Life Sciences Ltd $WVE. 

A Form 4 filing by GSK plc reports a purchase worth $22,335,440. 

In addition, a 13D filing from RA Capital Management reveals an increase in its ownership stake from 12.30% to 16.00%.

Here’s The Hot Corner, with data from September 30, 2024:

Control Empresarial de Capitales S.A. de C.V. continues to buy shares of Talos Energy Inc $TALO, reporting a purchase with a total value of $1,030,980.

D. E. Shaw & Company L.P filed a Form 4 revealing a $826,086 purchase in Ibotta Inc $IBTA.

WVE has been in the base-building process for roughly two years.

Price is currently piercing though the upper bounds of this base, suggesting a valid trend reversal.

As long as we’re above 7.10, the path of least resistance is higher for WVE.

Stay tuned. We'll be back on Thursday with more insider activity.

And please reach out with any questions. We love hearing from you!

For questions about your membership, contact us at 323-421-7910 or info@stockmarketmedia.com

Filed Under: